Showing results (1101-1110 of 1,512) with videos related to

Sort By:
Pageof 152
Neurocritical Care|July 22, 2025
Epidemiological Patterns and Variability in Acute Brain Injury: A Multicenter Registry Analysis in South Korea's Neurocritical Care UnitsHeewon Jeong, So Hee Park, Yoon-Hee Choo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2015
Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration statusJaemoon Koh, Heounjeong Go, Bhumsuk Keam, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 31, 2017
Usefulness of argon plasma coagulation ablation subsequent to endoscopic snare papillectomy for ampullary adenomaKwangwoo Nam, Tae Jun Song, Raymond E Kim, et al.
Arthritis and Rheumatism|September 2, 2006
Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: Regulation by cytokinesEon Jeong Nam, Keum Hee Sa, Dong Wan You, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancerByoung Chul Cho, Grace K Dy, Ramaswamy Govindan, et al.
Microvascular Research|August 30, 2008
TIMP-2 disrupts FGF-2-induced downstream signaling pathwaysDong-Wan Seo, Soo Hyeon Kim, Seok-Hyun Eom, et al.
Lung Cancer (Amsterdam, Netherlands)|September 9, 2019
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancerYu-Jung Kim, Bhumsuk Keam, Chan-Young Ock, et al.
ACS Applied Materials & Interfaces|March 13, 2025
Elucidating the Chirality-Induced Spin Selectivity Effect of Co-Doped NiO Deposited on Ni Foam for Highly Stable Zn-Air BatteriesYoung Sun Park, Jeongyoub Lee, Hyungsoo Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 13, 2023
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 TrialJames Chih-Hsin Yang, Geoffrey Liu, Shun Lu, et al.
Lung Cancer (Auckland, N.Z.)|February 4, 2020
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (<i>ALK</i>)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 StudiesShirish Gadgeel, Alice T Shaw, Fabrice Barlesi, et al.
Pageof 152